Shan Ahmed Khan

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Planet Labs Stock (PL) Surges on Dec. 22, 2025: Record Revenue, Raised FY2026 Outlook, Analyst Targets, and What Comes Next

Planet Labs Stock (PL) Surges on Dec. 22, 2025: Record Revenue, Raised FY2026 Outlook, Analyst Targets, and What Comes Next

Planet Labs PBC is back in the market spotlight on Monday, December 22, 2025, as the stock trades near record territory after a cascade of catalysts: a blowout fiscal Q3 revenue print, sharply higher contract backlog metrics, fresh satellite milestones for its next‑gen Pelican fleet, and a wave of analyst price‑target revisions. Investing.com+1
Zenas BioPharma (ZBIO) Stock Hits a Record High on Dec. 22, 2025 as INDIGO Phase 3 Catalyst Nears — Latest News, Analyst Forecasts, and What’s Next

Zenas BioPharma (ZBIO) Stock Hits a Record High on Dec. 22, 2025 as INDIGO Phase 3 Catalyst Nears — Latest News, Analyst Forecasts, and What’s Next

Zenas BioPharma, Inc. is having one of those classic biotech days where the market starts acting like it can see the future. On Monday, December 22, 2025, ZBIO surged roughly 14% and traded around $41.23 by early afternoon Eastern time—after touching a fresh all-time high near $41.67, according to multiple market data reports. MarketBeat+1
22 December 2025
Clearwater Analytics (CWAN) Stock Surges on $8.4 Billion Take-Private Deal: Price, Timeline, and What Analysts Are Saying (Dec. 22, 2025)

Clearwater Analytics (CWAN) Stock Surges on $8.4 Billion Take-Private Deal: Price, Timeline, and What Analysts Are Saying (Dec. 22, 2025)

Clearwater Analytics Holdings, Inc. is in the spotlight on December 22, 2025, after the company confirmed it has agreed to be acquired in an all-cash take-private transaction valued at about $8.4 billion. Shareholders are set to receive $24.55 per share in cash, a headline number that has quickly become the market’s “gravity well” for the stock. Reuters+2CWAN+2
Rocket Lab (RKLB) Stock Surges on $816M Space Force Satellite Contract and Record 2025 Launches — What News and Forecasts Say on Dec. 22, 2025

Rocket Lab (RKLB) Stock Surges on $816M Space Force Satellite Contract and Record 2025 Launches — What News and Forecasts Say on Dec. 22, 2025

Rocket Lab Corporation stock is starting the holiday-shortened week with a bang: shares pushed to fresh highs on Monday, December 22, 2025, extending a sharp rally that began late last week. The move follows two closely linked catalysts that investors tend to love in the same sentence: a “landmark” U.S. national security satellite contract and a record-setting year of flawless Electron launches. Investopedia+2Investors+2
Cytokinetics (CYTK) Stock Hits 52-Week High as FDA Approval of Myqorzo Triggers Analyst Price-Target Hikes

Cytokinetics (CYTK) Stock Hits 52-Week High as FDA Approval of Myqorzo Triggers Analyst Price-Target Hikes

Cytokinetics, Incorporated surged on Monday, December 22, 2025, extending a sharp rally that followed the company’s first-ever U.S. drug approval. Shares traded around $69.68 in the session, up roughly 11% from the prior close, after reaching an intraday high near $70.86—a move that pushed the biotech to fresh 52-week highs and re-focused Wall Street on the commercial potential of its newly approved heart drug, Myqorzo. Investing.com
22 December 2025
Rigetti Computing Stock (RGTI) News Today, Dec. 22, 2025: Shares Surge as Analyst Forecasts for 2026 Focus on Roadmap, Cash Runway, and High-Volatility Risks

Rigetti Computing Stock (RGTI) News Today, Dec. 22, 2025: Shares Surge as Analyst Forecasts for 2026 Focus on Roadmap, Cash Runway, and High-Volatility Risks

Rigetti Computing, Inc. is back in the spotlight on Monday, December 22, 2025, as quantum-computing stocks regain momentum. RGTI traded around $27 in Monday’s session, up roughly 14% on the day—another reminder that quantum “pure plays” can move fast in both directions. Finviz
Hut 8 Stock (HUT) Jumps on Benchmark’s Street-High $85 Target as $7 Billion AI Data Center Deal Re-Rates the Story

Hut 8 Stock (HUT) Jumps on Benchmark’s Street-High $85 Target as $7 Billion AI Data Center Deal Re-Rates the Story

Hut 8 Corp. is back in the spotlight on Monday, December 22, 2025, as the company’s shares extend a sharp rally tied to its pivot from crypto-native infrastructure toward AI and high-performance computing data centers. The latest catalyst: Benchmark raised its price target to a Street-high $85, arguing that Hut 8’s newly announced River Bend transaction marks a structural shift in the company’s revenue quality and durability. Investing.com+1
22 December 2025
ABIVAX Société Anonyme Stock (ABVX) Jumps on Fresh Eli Lilly Takeover Talk as Nasdaq Biotech Index Inclusion Takes EffectABIVAXABIVAX Société Anonyme Stock (ABVX) Jumps on Fresh Eli Lilly Takeover Talk as Nasdaq Biotech Index Inclusion Takes Effect

ABIVAX Société Anonyme Stock (ABVX) Jumps on Fresh Eli Lilly Takeover Talk as Nasdaq Biotech Index Inclusion Takes EffectABIVAXABIVAX Société Anonyme Stock (ABVX) Jumps on Fresh Eli Lilly Takeover Talk as Nasdaq Biotech Index Inclusion Takes Effect

PARIS / NEW YORK — December 22, 2025 — ABIVAX Société Anonyme stock is back in the spotlight on Monday after renewed takeover chatter tied to U.S. pharma giant Eli Lilly—arriving the same morning Abivax’s addition to the Nasdaq Biotechnology Index becomes effective. The combination is fueling a sharp move in ABVX shares and re-igniting debate about whether 2025’s biotech breakout is now morphing into an M&A story.
D-Wave Quantum Stock (QBTS) Jumps on CES 2026 Plans: News, Forecasts and Analysis (Dec. 22, 2025)

D-Wave Quantum Stock (QBTS) Jumps on CES 2026 Plans: News, Forecasts and Analysis (Dec. 22, 2025)

D-Wave Quantum Inc. is back in the spotlight on December 22, 2025—and not in a subtle way. Shares surged in Monday trading as investors reacted to fresh company news tied to CES 2026, the technology mega-event in Las Vegas. As of the latest available quote, QBTS traded around $31.19, up roughly 16% on the session, after swinging between $27.15 and $31.41 with volume above 28 million shares.
22 December 2025
1 420 421 422 423 424 609
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

Xylem

NYSE: XYL 94 / 100
#2 STRONG BUY

AerCap

NYSE: AER 92 / 100
#3 BUY ON WEAKNESS

Visa

NYSE: V 90 / 100
#4 BUY

Chevron

NYSE: CVX 86 / 100
#5 ACCUMULATE

UPS

NYSE: UPS 84 / 100
View full portfolio
Editorial model selection. Not personalised advice.